Antiangiogenic therapy for high‐grade glioma

Overview of attention for article published in Cochrane database of systematic reviews, September 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 10,524 followers.

RT @Cochrane_GNOCG: Insufficient evidence - Antiangiogenic therapy for high-grade glioma https://t.co/JHJpyoxJcy @CochraneLibrary

Insufficient evidence - Antiangiogenic therapy for high-grade glioma https://t.co/JHJpyoxJcy @CochraneLibrary

Cochrane review: ‘Insufficient evidence’ for antiangiogenic therapies in newly diagnosed glioblastoma http://t.co/6kMmnuzxke

Antiangiogenic therapy for highgrade glioma The Cochrane Library Khasraw Wiley Online Library http://t.co/z7kkwgTwXC

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.